FLAVONE

FLAVONE is a lipid of Polyketides (PK) class. Flavone is associated with abnormalities such as Cardiovascular Diseases, Cerebrovascular accident, DERMATITIS HERPETIFORMIS, FAMILIAL, Hyperinsulinism and Inflammatory disorder. The involved functions are known as Oxidation-Reduction, Metabolic Inhibition, Inflammation, Phosphorylation and antioxidant activity. Flavone often locates in Endothelium, Hepatic, Protoplasm, Body tissue and Extracellular. The associated genes with FLAVONE are ICAM1 gene, BCL2L1 gene, MYC gene, TP53 gene and cytochrome c''. The related lipids are Promega, Steroids and Total cholesterol. The related experimental models are Knock-out, Disease model and Animal Disease Models.

Cross Reference

Introduction

To understand associated biological information of FLAVONE, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with FLAVONE?

FLAVONE is suspected in Diabetes Mellitus, Non-Insulin-Dependent, Obesity, Chronic Disease, Disintegration, Cardiovascular Diseases, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with FLAVONE

MeSH term MeSH ID Detail
Weight Loss D015431 56 associated lipids
Stomach Ulcer D013276 75 associated lipids
Osteosarcoma D012516 50 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Pain D010146 64 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Melanoma D008545 69 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Per page 10 20 50 | Total 32

PubChem Associated disorders and diseases

What pathways are associated with FLAVONE

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with FLAVONE?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with FLAVONE?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with FLAVONE?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with FLAVONE?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with FLAVONE?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011) and Knock-out are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).

Disease model

Disease model are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).

Animal Disease Models

Animal Disease Models are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with FLAVONE

Download all related citations
Per page 10 20 50 100 | Total 1492
Authors Title Published Journal PubMed Link
Urba WJ et al. Enhancement of natural killer activity in human peripheral blood by flavone acetic acid. 1988 J. Natl. Cancer Inst. pmid:2452890
Weiss GR et al. New anticancer agents. 1988 Cancer Chemother Biol Response Modif pmid:2484323
Hornung RL et al. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2. 1988 J. Immunol. pmid:2460546
Yamazoe Y et al. Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P-450. 1988 Carcinogenesis pmid:3121205
Yamazoe Y et al. Metabolic activation of pyrolysate arylamines by human liver microsomes; possible involvement of a P-488-H type cytochrome P-450. 1988 Jpn. J. Cancer Res. pmid:3147272
Armand J et al. Flavonoids: a new class of anticancer agents? Preclinical and clinical data of flavone acetic acid. 1988 Prog. Clin. Biol. Res. pmid:3051027
Pratesi G et al. Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512). 1988 Br. J. Cancer pmid:3166904
Weiss RB et al. Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512). 1988 Cancer Res. pmid:3167843
Bibby MC et al. Experimental anti-tumor effects of flavone acetic acid (LM975). 1988 Prog. Clin. Biol. Res. pmid:3174695
Bibby MC et al. Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512). 1988 Br. J. Cancer pmid:3179187
Ching LM and Baguley BC Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512). 1988 Eur J Cancer Clin Oncol pmid:3181272
Damia G et al. Dose-dependent pharmacokinetics of flavone acetic acid in mice. 1988 Cancer Chemother. Pharmacol. pmid:3396145
Evelhoch JL et al. Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. 1988 Cancer Res. pmid:3409216
Gouyette A et al. Flavone acetic acid: a nonlinear pharmacokinetic model. 1988 Cancer Chemother. Pharmacol. pmid:3409441
Abdalla S et al. Effects of hispidulin, a flavone isolated from Inula viscosa, on isolated guinea-pig smooth muscle. 1988 Gen. Pharmacol. pmid:3410278
Hornung RL et al. Immunomodulation of natural killer cell activity by flavone acetic acid: occurrence via induction of interferon alpha/beta. 1988 J. Natl. Cancer Inst. pmid:3418728
Oberpichler H et al. Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. 1988 Pharmacol Res Commun pmid:3420139
Bissery MC et al. Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo. 1988 Cancer Res. pmid:3422592
Finlay GJ et al. Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effect. 1988 J. Natl. Cancer Inst. pmid:3351960
Giavazzi R et al. Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts. 1988 Br. J. Cancer pmid:3355765
Gachályi A et al. Mobilization of 85Sr by flavone derivatives (morin and ipriflavone) in normal and pregnant rats. 1988 Radiobiol Radiother (Berl) pmid:3186955
Chen JC et al. [Anti-arrhythmic action of 4'-methyl-7-([2-hydroxy-3-(beta-propinamidoethyl)amino]propoxy) flavone hydrochloride (SIPI-644)]. 1988 Zhongguo Yao Li Xue Bao pmid:3188948
Fisher RF et al. Specific binding of proteins from Rhizobium meliloti cell-free extracts containing NodD to DNA sequences upstream of inducible nodulation genes. 1988 Genes Dev. pmid:3288541
Hayashi T et al. A cytotoxic flavone from Scoparia dulcis L. 1988 Chem. Pharm. Bull. pmid:3246045
Abbiati GA et al. Receptor binding studies of the flavone, REC 15/2053, and other bladder spasmolytics. 1988 Pharm. Res. pmid:3247311
Wiltrout RH et al. Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer. 1988 J. Immunol. pmid:3258894
Rabinovitz M The structure of flavone-8-acetic acid, a chemotherapeutic agent, and its application to drug design. 1988 J. Enzym. Inhib. pmid:3236069
Robbins RC Flavones in citrus exhibit antiadhesive action on platelets. 1988 Int J Vitam Nutr Res pmid:3243696
Armitage JP et al. Comparison of the chemotactic behaviour of Rhizobium leguminosarum with and without the nodulation plasmid. 1988 Mol. Microbiol. pmid:3210967
Bourdillat B et al. Mechanism of action of hispidulin, a natural flavone, on human platelets. 1988 Prog. Clin. Biol. Res. pmid:2845433
Hirano T et al. Effects of synthetic and naturally occurring flavonoids on Na+,K+-ATPase: aspects of the structure-activity relationship and action mechanism. 1989 Life Sci. pmid:2552245
Cummings J and Smyth JF Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours. 1989 Cancer Chemother. Pharmacol. pmid:2667786
Kerr DJ and Kaye SB Flavone acetic acid--preclinical and clinical activity. 1989 Eur J Cancer Clin Oncol pmid:2680512
Bonnay M et al. [Flavone acetic acid and LY 186641 interfere in various ways in Jaffé's reaction]. 1989 Bull Cancer pmid:2620109
Tranchand B et al. [Phase I pharmacokinetics of flavone-acetic acid]. 1989 Bull Cancer pmid:2620114
Hill S et al. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action. 1989 Eur J Cancer Clin Oncol pmid:2591434
Ching LM and Baguley BC Hyporesponsiveness of macrophages from C3H/HeJ (endotoxin-resistant) mice to the antitumour agent flavone acetic acid (NSC 347512). 1989 Eur J Cancer Clin Oncol pmid:2591444
Chabot GG et al. Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice. 1989 Cancer Chemother. Pharmacol. pmid:2597279
Ching LM and Baguley BC Reduction of cytotoxic effector cell activity in colon 38 tumours following treatment with flavone acetic acid. 1989 Eur J Cancer Clin Oncol pmid:2597283
Baguley BC et al. Comparison of the effects of flavone acetic acid, fostriecin, homoharringtonine and tumour necrosis factor alpha on colon 38 tumours in mice. 1989 Eur J Cancer Clin Oncol pmid:2702981
Lewis CR et al. Autonomic neuropathy following treatment with flavone acetic acid. 1989 Eur J Cancer Clin Oncol pmid:2703010
Nagai T et al. Inhibition of mouse liver sialidase by plant flavonoids. 1989 Biochem. Biophys. Res. Commun. pmid:2775264
Sun JR and Brown JM Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma. 1989 Cancer Res. pmid:2790784
Murray JC et al. Flavone acetic acid induces a coagulopathy in mice. 1989 Br. J. Cancer pmid:2803949
Relling MV et al. Anticancer drugs as inhibitors of two polymorphic cytochrome P450 enzymes, debrisoquin and mephenytoin hydroxylase, in human liver microsomes. 1989 Cancer Res. pmid:2908853
Wu ES et al. Flavones. 2. Synthesis and structure-activity relationship of flavodilol and its analogues, a novel class of antihypertensive agents with catecholamine depleting properties. 1989 J. Med. Chem. pmid:2909730
Bibby MC et al. Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. 1989 J. Natl. Cancer Inst. pmid:2911084
Lonchampt M et al. Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study. 1989 Arzneimittelforschung pmid:2818676
Lee DW and Park KH Testosterone metabolism by microsomal cytochrome P-450 in liver of rats treated with some inducers. 1989 Int. J. Biochem. pmid:2502444
Ferrari F et al. Structures of three new flavone derivatives, brosimones G, H, and I, from Brosimopsis oblongifolia. 1989 Planta Med. pmid:17262259